CME Group sr md Julie Winkler sells $3.08M in common stock

Julie Winkler, Senior Managing Director and Chief Commercial Officer at CME Group Inc., divested 10,079 shares of the company's Class A common stock on November 2, 2026. The sale spanned multiple transactions at prices between $305.11 and $305.34, totaling $3,075,606. Post-sale, Ms. Winkler retains 21,482 shares of CME Group Class A common stock.

This insider transaction occurred amidst CME Group's robust stock performance, with shares trading at $306.24, marking a 4.35% increase over the past week. Investment research suggests the stock is currently overvalued compared to its intrinsic value. CME Group boasts a market capitalization of $108.5 billion and provides a dividend yield of 1.72%.

For a more in-depth analysis of CME's valuation, including over eight InvestingPro Tips, refer to the detailed Pro Research Report. In related news, CME Group reported surpassing third-quarter 2026 earnings expectations, with adjusted earnings per share at $3.02, surpassing the anticipated $2.98. Revenue for the quarter reached $1.74 billion, a 13% increase year-over-year.

UBS raised its price target for CME Group stock to $310, citing robust revenue growth and EPS beat, while maintaining a Neutral rating. JPMorgan upgraded CME Group from Underweight to Overweight, with a price target of $367, highlighting a favorable rates outlook. Notably, high-frequency trading firms such as Jane Street and Hudson River Trading are investing heavily in AI computing infrastructure to bolster their machine learning capabilities.

Interactive Brokers launched autonomous trading on October 21, allowing users to execute trades without manual approval, supporting 75,000 global stocks, options, and ETFs. Jefferies observed the ongoing expansion of AI trading tools across leading brokerage platforms, underscoring significant advancements since their June analysis.